All lobbying filings
S-3 Group
S-3 Group filed a Q3 report for Abbott Laboratories on October 16, 2026, reporting $60,000 in lobbying income.
Lobbying for Abbott Laboratories · Healthcare technology company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 16, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Illinois
Lobbyists on this filing
6
-
MATT BRAVOPreviously held: Director of Floor Operations for Maj. Whip Steve Scalise; Prof Staff, E&C; Floor Asst to Maj. Leader Eric Cantor
-
MARTIN REISERPreviously held: Policy Director, Republican Whip Steve Scalise, professional staff House Ways and Means Committee, Chief of Staff, Rep. Dan Miller, Budget Associate, House Budget Committee
-
CHANDA BETOURNEYPreviously held: Dep. Staff Director and Chief Counsel, Senate Appropriations Cmt; Chief Counsel Civil Law and Oversight, Sen. Counsel, Sen. Judiciary Cmt; Leg Asst. and Projects Dir., Leg. Corresp., Senator Leahy
-
CHRISTOPHER BUKIPreviously held: Staff Assistant/Legislative Correspondent, Representative John Culberson; Legislative Assistant/Senior Legislative Assistant, Representative Bill Shuster; Legislative Director/Deputy Chief of Staff, Representative David McKinley
-
KRISTI REMINGTONPreviously held: Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee
-
MARTIN DELGADOPreviously held: Staff Dir, House Ag Approps, MilCon/VA Approps; Prof Staff, House Ag Approps, Senate Interior Approps; Budget Analysis, USDA APHIS
Government bodies contacted
2
Lobbying activity
4
Issues related to infant formula
Equitable Access to Community Pharmacist Services Act
Equitable Access to Community Pharmacist Services Act
Proposals to reform domestic and international tax structures